Want to see JP:8129 full AI Analyst Report?
8129 Stock Chart & Stats
¥5098.00
-¥20.00(-0.47%)
At close: 4:00 PM EST
¥5098.00
-¥20.00(-0.47%)
Day’s Range― - ―
52-Week Range¥3,574.00 - ¥5,726.00
Previous CloseN/A
Volume198.00K
Average Volume (3M)153.50K
Market Cap
¥246.23B
Enterprise Value¥150.71K
Total Cash (Recent Filing)¥94.36B
Total Debt (Recent Filing)¥9.89B
Price to Earnings (P/E)14.9
Beta0.16
Next Earnings
Nov 06, 2026EPS Estimate
43.15Next Dividend Ex-DateN/A
Dividend Yield4.38%
Share Statistics
EPS (TTM)270.02
Shares Outstanding73,025,940
10 Day Avg. Volume107,250
30 Day Avg. Volume153,503
Financial Highlights & Ratios
PEG Ratio-1.31
Price to Book (P/B)1.12
Price to Sales (P/S)0.20
P/FCF Ratio23.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,600.00Price Target Upside-9.77% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)187.7
Revenue Forecast (FY)¥1.60T
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageVery low and falling leverage gives durable financial flexibility: it lowers refinancing and solvency risk, supports steady dividend capacity or opportunistic M&A, and cushions operating volatility. Over 2–6 months this underpins resilience to shocks and strategic optionality.
Steady Revenue Growth From DistributionConsistent top-line expansion reflects resilient demand for pharmaceutical distribution and recurring wholesale margins. Stable volume and service fees reduce revenue cyclicality, supporting predictable core cash inflows and capacity to maintain customer relationships over the medium term.
Improved Free Cash Flow Coverage In 2026Rebound in free cash flow that covered a large share of earnings in 2026 indicates recovering cash conversion and operational cash generation. That enhances ability to fund dividends, reduce debt further, or invest in logistics over the medium term despite prior variability.
Bears Say
Structurally Thin ProfitabilityVery narrow gross and net margins limit the company’s ability to absorb input cost increases or invest behind growth initiatives. Over several months this reduces margin headroom, heightens sensitivity to pricing pressure in distribution, and constrains retained earnings for reinvestment.
Uneven Cash-flow ConversionA year of negative operating and free cash flow highlights working-capital or timing volatility. Inconsistent cash conversion reduces forecasting reliability, may force short-term financing or limit capital allocation flexibility, and raises execution risk over the medium term.
Recent Earnings DeteriorationDeclining net income across 2024–2026 indicates pressure on profitability drivers. Persistent earnings softness can erode return on equity and limit the company’s ability to expand services or invest in efficiency, creating a multi-month headwind to improving operating metrics.
Toho Holdings Co., Ltd. News
8129 FAQ
What was Toho Holdings Co., Ltd.’s price range in the past 12 months?
Toho Holdings Co., Ltd. lowest stock price was ¥3574.00 and its highest was ¥5726.00 in the past 12 months.
What is Toho Holdings Co., Ltd.’s market cap?
Toho Holdings Co., Ltd.’s market cap is ¥246.23B.
When is Toho Holdings Co., Ltd.’s upcoming earnings report date?
Toho Holdings Co., Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 86 days.
How were Toho Holdings Co., Ltd.’s earnings last quarter?
Toho Holdings Co., Ltd. released its earnings results on Aug 05, 2026. The company reported ¥36.24 earnings per share for the quarter, missing the consensus estimate of ¥45.483 by -¥9.243.
Is Toho Holdings Co., Ltd. overvalued?
According to Wall Street analysts Toho Holdings Co., Ltd.’s price is currently Overvalued.
Does Toho Holdings Co., Ltd. pay dividends?
Toho Holdings Co., Ltd. pays a Semiannually dividend of ¥90 which represents an annual dividend yield of 4.38%. See more information on Toho Holdings Co., Ltd. dividends here
What is Toho Holdings Co., Ltd.’s EPS estimate?
Toho Holdings Co., Ltd.’s EPS estimate is 43.15.
How many shares outstanding does Toho Holdings Co., Ltd. have?
Toho Holdings Co., Ltd. has 73,025,940 shares outstanding.
What happened to Toho Holdings Co., Ltd.’s price movement after its last earnings report?
Toho Holdings Co., Ltd. reported an EPS of ¥36.24 in its last earnings report, missing expectations of ¥45.483. Following the earnings report the stock price went down -7.596%.
Which hedge fund is a major shareholder of Toho Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:8129
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Toho Holdings Co., Ltd.
Toho Holdings Co., Ltd. serves as a leading wholesaler of pharmaceutical and healthcare products throughout Japan. Its extensive product range includes prescription and over-the-counter medications, reagents, medical devices and supplies, and health foods, in addition to offerings for preventive, clinical, community, and home-based medical and nursing care. Beyond distribution, the company provides comprehensive support services like developing and selling customer-focused software, assisting with the establishment of new medical facilities and pharmacies, delivering management consulting, offering medical assistance, and facilitating personnel recruitment. Toho Holdings also operates dispensing pharmacies, manufactures and distributes generic drugs, acts as a site management organization (SMO) to support clinical trials for various healthcare institutions, and supplies specialized software to the medical sector. Among its technological solutions are customer support systems such as ENIF for pharmaceutical ordering, ENI-Pharmacy for streamlining dispensing and prescribing processes, LXMATE HeLios for medical appointments, KAITOS for online medical consultations and medication guidance, ENIFwin for inventory control in large hospitals, the ENIFvoice series for voice-activated electronic medication history recording, and ENIF Nurse for home-visit nurse operational support, along with diverse logistics systems. The company, founded in 1948, is headquartered in Tokyo, Japan.
8129 Stock 12 Month Forecast
Average Price Target
¥4,600.00
▼(-9.77% Downside)
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Eisai Co
―
Shionogi & Co
―
Takeda Pharmaceutical Co
―
Nippon Shinyaku Co., Ltd.
―








